Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-31
2006-10-31
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S902000
Reexamination Certificate
active
07129218
ABSTRACT:
Various methods are provided, including re-epithelization and wound healing with reduced fibrosis, particularly for the re-epithelization of mucous membrane tissues, most particularly for the treatment and prevention of gum disease and for periodontal regeneration, each of which uses administration of a composition containing one or more rhamnolipids as an active ingredient. The figure provides a graphical representation of the effects of topical BAC-3 on the rate of burn wound closure.
REFERENCES:
patent: 5254538 (1993-10-01), Holick et al.
patent: 5409703 (1995-04-01), McAnalley et al.
patent: 5514661 (1996-05-01), Piljac et al.
patent: 5652274 (1997-07-01), Martin
patent: WO 99/43334 (1999-02-01), None
patent: 99/433334 (1999-09-01), None
Periodontal Regeneration, Research, Science and Therapy Committee, The American Academyh of Periodontology, Scientific, Clinical and Educational Affairs Dept. May 1993.
Dujmic Tatjana
Piljac Goran
Piljac Jasenka
Piljac Tihana
Stipcevic Tamara
Krass Frederick
Paradigm Biomedical, Inc.
Whitham Curtis Christofferson & Cook PC
LandOfFree
Use of rhamnolipids in wound healing, treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of rhamnolipids in wound healing, treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rhamnolipids in wound healing, treatment and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714810